Visualitza per autor "Bang, Yung-Jue"
Ara mostrant els elements 1-4 d 4
-
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
Tabernero Caturla, Josep; Van Cutsem, Eric; Fuchs, Charles; Janjigian, Yelena; Bhagia, Pooja; Bang, Yung-Jue (Future Medicine, 2021-08) -
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Darren Wan-Teck; Azaro Pedrazzoli, Analía Beatriz; Bauer, Todd; Bang, Yung-Jue (Wiley, 2020-02) -
Quality of life with first-line pembrolizumab for PD-L1–positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
Van Cutsem, Eric; Valderrama, A.; Fuchs, Charles; Shitara, Kohei; Janjigian, Yelena; Alsina Maqueda, Maria; Bang, Yung-Jue (Elsevier, 2021-08) -
Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens
Bang, Yung-Jue; Ryu, Min-Hee; FAGNIEZ, Nathalie; Tabernero, Josep; Bedard, Philippe; Vieito , Maria (American Association for Cancer Research, 2023-08)